Literature DB >> 11782970

Tumor necrosis factor expressed by primary hippocampal neurons and SH-SY5Y cells is regulated by alpha(2)-adrenergic receptor activation.

A E Renauld1, R N Spengler.   

Abstract

Neuron expression of the cytokine tumor necrosis factor-alpha (TNF), and the regulation of the levels of TNF by alpha(2)-adrenergic receptor activation were investigated. Adult rat hippocampal neurons and phorbol ester (PMA)-differentiated SH-SY5Y cells were examined. Intracellular levels of TNF mRNA accumulation, as well as TNF protein and that released into the supernatant were quantified by in situ hybridization, immunocytochemistry and bioanalysis, respectively. Both neuron cultures demonstrated constitutive production of TNF. Activation of the alpha(2)-adrenergic receptor increased intracellular levels of TNF mRNA and protein in SH-SY5Y cells after addition of graded concentrations of the selective agonist, Brimonidine (UK-14304) to parallel cultures. Intracellular levels of mRNA were increased in a concentration-dependent fashion within 15 min of UK-14304 addition and were sustained during 24 hr of receptor activation. In addition, the levels of TNF in the supernatant were increased in both types of neuron cultures within 15 min of alpha(2)-adrenergic receptor activation. Furthermore, levels of TNF significantly increased in the supernatants of both neuron cultures after potassium-induced depolarization. A reduction in this depolarization-induced release occurred in hippocampal neuron cultures after exposure to the sympathomimetic tyramine with media replacement to deplete endogenous catecholamines. This finding reveals a role for endogenous catecholamines in the regulation of TNF production. Potassium-induced depolarization resulted in the release of TNF in hippocampal neuron cultures within 15 min but not until 24 hr in SH-SY5Y cultures demonstrating a temporally mediated event dependent upon cell type. Neuron expression of TNF, regulated by alpha(2)-adrenergic receptor activation demonstrates not only how a neuron controls its own production of this pleiotropic cytokine, but also displays a normal role for neurons in directing the many functions of TNF. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782970     DOI: 10.1002/jnr.10101

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  10 in total

1.  Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release.

Authors:  Robert N Spengler; Reeteka Sud; Paul R Knight; Tracey A Ignatowski
Journal:  Neuropharmacology       Date:  2006-10-18       Impact factor: 5.250

2.  Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system.

Authors:  Jing Chen; Jessica B Buchanan; Nathan L Sparkman; Jonathan P Godbout; Gregory G Freund; Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2007-10-24       Impact factor: 7.217

3.  Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line.

Authors:  Erian H Girgis; John P Mahoney; Rafaat H Khalil; Magdi R Soliman
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

4.  Tumor necrosis factor alpha regulates responses to nerve growth factor, promoting neural cell survival but suppressing differentiation of neuroblastoma cells.

Authors:  Yoshinori Takei; Ronald Laskey
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

5.  Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).

Authors:  Mark R Hutchinson; Susannah S Lewis; Benjamen D Coats; David A Skyba; Nicole Y Crysdale; Debra L Berkelhammer; Anita Brzeski; Alexis Northcutt; Christine M Vietz; Charles M Judd; Steven F Maier; Linda R Watkins; Kirk W Johnson
Journal:  Brain Behav Immun       Date:  2008-10-04       Impact factor: 7.217

6.  Proteus mirabilis Urease: Unsuspected Non-Enzymatic Properties Relevant to Pathogenicity.

Authors:  Matheus V C Grahl; Augusto F Uberti; Valquiria Broll; Paula Bacaicoa-Caruso; Evelin F Meirelles; Celia R Carlini
Journal:  Int J Mol Sci       Date:  2021-07-04       Impact factor: 5.923

7.  Rosiglitazone as a Modulator of TLR4 and TLR3 Signaling Pathways in Rat Primary Neurons and Astrocytes.

Authors:  Dmitry V Chistyakov; Nadezda V Azbukina; Alexandr V Lopachev; Ksenia N Kulichenkova; Alina A Astakhova; Marina G Sergeeva
Journal:  Int J Mol Sci       Date:  2018-01-02       Impact factor: 5.923

8.  Antidepressant drugs modulate growth factors in cultured cells.

Authors:  Andreas W Henkel; Wolfgang Sperling; Andrea Rotter; Udo Reulbach; Cornelia Reichardt; Dominikus Bönsch; Juan M Maler; Johannes Kornhuber; Jens Wiltfang
Journal:  BMC Pharmacol       Date:  2008-03-04

9.  Modulation of lipopolysaccharide-induced neuronal response by activation of the enteric nervous system.

Authors:  Sabrina Coquenlorge; Emilie Duchalais; Julien Chevalier; Francois Cossais; Malvyne Rolli-Derkinderen; Michel Neunlist
Journal:  J Neuroinflammation       Date:  2014-12-12       Impact factor: 8.322

Review 10.  Lipids Nutrients in Parkinson and Alzheimer's Diseases: Cell Death and Cytoprotection.

Authors:  Thomas Nury; Gérard Lizard; Anne Vejux
Journal:  Int J Mol Sci       Date:  2020-04-03       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.